SCHEMBL9130654

SCHEMBL9130654

O=C(C#Cc1ccccn1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.49
NTSR1 P30989 1/20 0.49
FFAR1 O14842 1/20 0.47
KMT2A Q03164 2/20 0.46
VCP P55072 1/20 0.45
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
GRM5 P41594 4/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KCNH2 Q12809 1/20 0.41
KDM4E B2RXH2 1/20 0.41
KDM6B O15054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30898828 1.00 HSP90AA1 (0.49) HSP90AA1NTSR1FFAR1KMT2AVCP
SCHEMBL2560784 0.83 FFAR1 (0.50) FFAR1KMT2AGRM5CYP1A2LMNA
SCHEMBL9133103 0.83 APP (0.52) KMT2AVCPGRM5SMN1; SMN2NPC1
SCHEMBL1390131 0.81 GRM5 (0.50) FFAR1VCPGRM5CYP1A2KCNH2
SCHEMBL18104914 0.81 FFAR1 (0.47) FFAR1GRM5CYP1A2LMNANAPRT
SCHEMBL30475553 0.78 FFAR1 (0.45) FFAR1GRM5CYP1A2L3MBTL1KCNH2
SCHEMBL13382197 0.78 GRM5 (0.49) FFAR1GRM5CYP1A2L3MBTL1KCNH2
SCHEMBL3641140 0.75 RAB9A (0.45) FFAR1KMT2AGRM5SMN1; SMN2NPC1
Methyl Alcohol SCHEMBL28902013 0.74 GRM5 (0.67) FFAR1GRM5CYP1A2L3MBTL1KCNH2
SCHEMBL20089267 0.74 GRM5 (0.45) FFAR1GRM5CYP1A2L3MBTL1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0476645-B1 Calcium uptake inhibitors MERRELL DOW PHARMA (US) 1995-09-06 EP disclosed
US-5409942-A Administering 1-phenyl-3-aryl-2-propyne-1-ones compounds MERRELL DOW PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
US-5223518-A Controlling intake in leukocytes and platelets MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-29 US disclosed
EP-0476645-A1 Calcium uptake inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-25 EP disclosed